Leerink Swann Upgrades athenahealth (ATHN) to Outperform; Strong Growth Still Expected
Tweet Send to a Friend
Get Alerts ATHN Hot Sheet
Price: $85.24 +0.04%
Rating Summary:
7 Buy, 12 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Rating Summary:
7 Buy, 12 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Trade ATHN Now!
Leerink Swann upgraded athenahealth (NASDAQ: ATHN) from Market Perform to Outperform with a price target range of $59-$60.
Leerink analyst says, "At yesterday's Investor Day conference management provided 2012 adjusted EPS guidance of $0.85-$0.97 which was well below our estimate and consensus of $1.15. While 2012 will be a year of higher investment spend, (1) revenue is still expected to grow 30% per year and nearly all of the revenue is recurring, (2) we believe the quality of the software and service is very high, and (3) we believe margins tied to Anodyne, Proxsys, Coordinator, and Clinicals will improve in late 2012 which implies better earnings growth in 2013."
"We are reducing our 2012E EPS by $0.15 to $1.00 and we lower our 2013E EPS by $0.40 to $1.25, in order to reflect increased investment spend, mostly via higher cost-of-service. While we believe 2012 will be a year of increased costs, we believe 2013 margins should improve."
For an analyst ratings summary and ratings history on athenahealth click here. For more ratings news on athenahealth click here.
Shares of athenahealth closed at $49.04 yesterday, with a 52 week range of $38.08-$72.70.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Leerink analyst says, "At yesterday's Investor Day conference management provided 2012 adjusted EPS guidance of $0.85-$0.97 which was well below our estimate and consensus of $1.15. While 2012 will be a year of higher investment spend, (1) revenue is still expected to grow 30% per year and nearly all of the revenue is recurring, (2) we believe the quality of the software and service is very high, and (3) we believe margins tied to Anodyne, Proxsys, Coordinator, and Clinicals will improve in late 2012 which implies better earnings growth in 2013."
"We are reducing our 2012E EPS by $0.15 to $1.00 and we lower our 2013E EPS by $0.40 to $1.25, in order to reflect increased investment spend, mostly via higher cost-of-service. While we believe 2012 will be a year of increased costs, we believe 2013 margins should improve."
For an analyst ratings summary and ratings history on athenahealth click here. For more ratings news on athenahealth click here.
Shares of athenahealth closed at $49.04 yesterday, with a 52 week range of $38.08-$72.70.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Sears Holding Corp. (SHLD) Reports Q1 Loss of $1.29
- Sidoti Upgrades REX American Resources (REX) to Buy
- Deutsche Bank Upgrades Seagate (STX) to Buy; Sanmina (SANM) Cut to Sell, Flextronics (FLEX) & Fabrinet (FN) Cut to Hold
Create E-mail Alert Related Categories
UpgradesRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
